Clinical Evaluation and Drug Therapy of Refractory Constipation
10.3969/j.issn.1008-7125.2021.03.012
- Author:
Lingling HE
1
;
Hongshan WEI
1
;
Cheng ZHANG
2
;
Rongrong ZHOU
3
Author Information
1. Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University
2. Department of Gastroenterology, Beijing Tongren Hospital, Capital Medical University
3. Department of Gastroenterology, Qingdao Municipal Hospital
- Publication Type:Journal Article
- Keywords:
Defecatory Disorders;
Drug Therapy;
Functional Constipation;
Irritable Bowel Syndrome With Constipation;
Refractory Constipation
- From:
Chinese Journal of Gastroenterology
2021;26(3):186-189
- CountryChina
- Language:Chinese
-
Abstract:
Refractory constipation usually refers to constipation with no response to 4 weeks of drug treatment or 3 months of pelvic floor biofeedback training. Chronic constipation is a common disease mainly affecting middle-aged and elderly individuals. However, less than 20% of the patients have received clinical evaluation and systematic intervention. According to the symptoms and results of anorectal function test, patients with chronic constipation can be generally classified as functional constipation, irritable bowel syndrome with constipation and defecatory disorders. This article made a brief summary on the clinical evaluation and drug therapy of refractory constipation.
